Chen, X., Li, D., Jin, Y., Liu, W., Yang, S., Ding, Y., Li, J., Ding, C., Guan, Y., Chen, Y., Zhou, Z., Li, Y., Sun, X., Zhang, X., Qiu, H. (2026). Perioperative chemotherapy plus disitamab vedotin (RC48) and toripalimab in HER2-overexpressed locally advanced gastric or gastroesophageal junction cancer (PERISCOPE-02): An open-label, single-arm, phase 2 trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.4080